Impact of Adaptive Radiotherapy on Locally Advanced Head and Neck Cancer - A Dosimetric and Volumetric Study

  • Dewan, Abhinav ;
  • Sharma, SK ;
  • Dewan, AK. ;
  • Srivastava, Himanshu ;
  • Rawat, Sheh ;
  • Kakria, Anjali ;
  • Mishra, Maninder ;
  • Suresh, T ;
  • Mehrotra, Krati
  • Published : 2016.04.11


Objective of the study is to evaluate volumetric and dosimetric alterations taking place during radiotherapy for locally advanced head and neck cancer (LAHNC) and to assess benefit of replanning in them. Materials and Methods: Thirty patients with LAHNC fulfilling the inclusion and exclusion criteria were enrolled in a prospective study. Planning scans were acquired both pre-treatment and after 20 fractions (mid-course) of radiotherapy. Single plan (OPLAN) based on initial CT scan was generated and executed for entire treatment course. Beam configuration of OPLAN was applied to anatomy of interim scan and a hybrid plan (HPLAN30) was generated. Adaptive replanning (RPLAN30) for remaining fractions was done and dose distribution with and without replanning compared for remaining fractions. Results: Substantial shrinkage of target volume (TV) and parotids after 4 weeks of radiotherapy was reported (p<0.05). No significant difference between planned and delivered doses was seen for remaining fractions. Hybrid plans showed increase in delivered dose to spinal cord and parotids for remaining fractions. Interim replanning improved homogeneity of treatment plan and significantly reduced doses to cord (Dmax, D2% and D1%) and ipsilateral parotid (D33%, D50% and D66%) (p<0.05). Conclusions: Use of one or two mid-treatment CT scans and replanning provides greater normal tissue sparing along with improved TV coverage.


Adaptive radiotherapy;dosimetric analysis;anatomical changes;locally advanced head and neck cancer


  1. Barker JL Jr, Garden AS, Ang KK, et al (2004). Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and- neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys, 59, 960-70.
  2. Beltran M, Ramos M, Rovira JJ, et al (2012). Dose variations in tumor volumes and organs at risk during IMRT for head-and-neck cancer. J Appl Clin Med Phys, 13, 3723.
  3. Berwouts D, Olteanu LA, Duprez F, et al (2013). Three-phase adaptive dose-painting-by-numbers for head-and-neck cancer: initial results of the phase I clinical trial. Radiother Oncol, 107, 310-6.
  4. Bhandari V, Patel P, Gurjar OP, et al (2014). Impact of repeat computerized tomography replans in the radiation therapy of head and neck cancers. J Med Phys, 39, 164-8.
  5. Bhinde SA, Davies M, Burke K, et al (2010). Weekly volumetric and dosimetric changes during chemoradiotherapy with IMRT for head and neck tumours: A prospective observational study. Int J Radiat Oncol Biol Phys, 76, 1360-8.
  6. Blanco AI, Chao KSC, El Naqa I, et al (2005). Dose-volume modelling of salivary function in patients with head-and-neck cancer receiving radiotherapy. Int J Radiat Oncol Biol Phys, 62, 1055-69.
  7. Brouwer CL, Steenbakkers RJ, Langendijik JA, et al (2015). Identifying patients who may benefit from adaptive radiotherapy: Does the literature on anatomic and dosimetric changes in head and neck organs at risk during radiotherapy provide information to help? Radiother Oncol, 115, 285-94.
  8. Budach W, Bolke E, Fietkau R, et al (2011). Evaluation of time, attendance of medical staff, and resources during radiotherapy for head and neck cancer patients: the DEGRO-QUIRO trial. Strahlenther Onkol, 187, 449-60.
  9. Castadot P, Lee JA, Geets X, et al (2010). Adaptive Radiotherapy of Head and Neck Cancer. Semin Radiat Oncol, 20, 84-93.
  10. Castadot P, Geets X, Lee JA, et al (2011). Adaptive functional image-guided IMRT in pharyngo-laryngeal squamous cell carcinoma: Is the gain in dose distribution worth the effort? Radiother Oncol, 101, 343-50.
  11. Castelli J, Simon A, Louvel G, et al (2015). Impact of head and neck cancer adaptive radiotherapy to spare the parotid glands and decrease the risk of xerostomia. Radiother Oncol, 10, 6.
  12. Charles B. Simone II a, David Ly, et al (2011). Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer, Radiother Oncol, 101, 376-82.
  13. Chen AM, Daly ME, Cui J, et al (2014). Clinical outcomes among patients with head and neck cancer treated by intensity-modulated radiotherapy with and without adaptive replanning. Head Neck, 36, 1541-6.
  14. Cheng HCY, Vincent W.C, Roger K.C, et al (2012). A prospective study on volumetric and dosimetric changes during intensity-modulated radiotherapy for nasopharyngeal carcinoma patients. Radiother Oncol, 104, 317-23.
  15. Daisne JF, Blumhofer A (2013). Atlas-based automatic segmentation of head and neck organs at risk and nodal target volumes: a clinical validation. Radiother Oncol, 8, 154.
  16. Geets X, Tomsej M, Lee JA, et al (2007). Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumors. Impact on target volume delineation and dose distribution using helical tomotherapy. Radiother Oncol, 85, 105-15.
  17. Han C, Chen YJ, Liu A, et al (2008). Actual dose variation of parotid glands and spinal cord for nasopharyngeal cancer patients during radiotherapy. Int J Radiat Oncol Biol Phys, 70, 1256-62.
  18. Hansen EK, Bucci MK, Quivey JM, et al (2006). Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys, 64, 355-62.
  19. Ho KF, Moore C, Webster G (2012). Monitoring dosimetric impact of weight loss with kilovoltage (KV) cone beam CT (CBCT) during parotid-sparing IMRT and concurrent chemotherapy. Int J Radiation Oncol Biol Phys, 82, 375-82.
  20. Hunter KU, Fernandes LL, Vineberg KA (2013). Parotid glands dose-effect relationships based on their actually delivered doses: implications for adaptive replanning in radiation therapy of head-and-neck cancer. Int J Radiat Oncol Biol Phys, 87, 676-82.
  21. Jensen AD, Nill S, Huber PE, et al (2012).Clinical concept for interfractional adaptive radiation therapy in the treatment of head-and-neck cancer. Int J Radiat Oncol Biol Phys, 82, 590-6.
  22. Kuo YC, Wu TH, Chung TS, et al (2006). Effect of regression of enlarged neck lymph nodes on radiation doses received by parotid glands during intensity-modulated radiotherapy for head and neck cancer. Am J Clin Oncol, 29, 600-5.
  23. Lee C, Langen KM, Lu W, et al (2008). Assessment of parotid gland dose changes during head and neck cancer radiotherapy using daily megavoltage computed tomography and deformable image registration. Int J Radiat Oncol Biol Phys, 71, 1563-71.
  24. Mohan R, Zhang X, Wang H, et al (2005). Use of deformed intensity distributions for on-line modification of image-guided IMRT to account for interfractional anatomic changes. Int J Radiat Oncol Biol Phys, 61, 1258-66.
  25. Nath SK, Simpson DR, Rose BS, et al (2009). Recent advances in image-guided radiotherapy for head and neck carcinoma. J Oncol, 2009.
  26. Nishi T, Nishimura Y, Shibata T, et al (2013). Volume and dosimetric changes and initial clinical experience of a two-step adaptive intensity modulated radiation therapy (IMRT) scheme for head and neck cancer. Radiother Oncol, 106, 85-9.
  27. O'Daniel JC, Garden AS, Schwartz DL, et al (2007). Parotid gland dose in intensity-modulated radiotherapy for head and neck cancer: Is what you plan what you get? Int J Radiat Oncol Biol Phys, 69, 1290-93.
  28. Sanguineti G, Ricchetti F, Thomas O, et al (2013). Pattern and predictors of volumetric change of parotid glands during intensity modulated radiotherapy. Br J Radiol, 86, 20130363.
  29. Schwartz DL, Garden AS, Thomas J et al (2012). Adaptive Radiotherapy for Head-and-Neck Cancer: Initial Clinical Outcomes from a Prospective Trial. Int J Radiation Oncol Biol Phys, 83, 986-93.
  30. Vasquez Osorio EM, Hoogeman MS, Al-Mamgani A, et al (2008). Local anatomic changes in parotid and submandibular glands during radiotherapy for oropharynx cancer and correlation with dose, studied in detail with nonrigid registration. Int J Radiat Oncol Biol Phys, 70, 875-82.
  31. Wang W, Yang H, Hu W et al (2010). Clinical study of the necessity of replanning before the 25th fraction during the course of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 77, 617-21.
  32. Wang ZH, Yan C, Zhang ZY, et al (2009). Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study. Laryngoscope, 119, 1966-74.
  33. Woodford C, Yartsev S, Dar R Bauman G (2007). Adaptive radiotherapy planning on decreasing gross tumor volumes as seen on megavoltage computed tomography images. Int J Radiat Oncol Biol Phys, 69, 1316-22.
  34. Wu Q, Chi Y, Chen PY, et al (2009). Adaptive replanning strategies accounting for shrinkage in head and neck IMRT. Int J Radiat Oncol Biol Phys, 75, 924-32.
  35. Yan D, Lockman D (2001). Organ/patient geometric variation in external beam radiotherapy and its effect. Med Phys, 28, 593-602.
  36. Zhao L, Wan Q, Zhou Y, et al (2011). The role of replanning in fractionated intensity modulated radiotherapy for nasopharyngeal carcinoma. Radiother Oncol, 98, 23-7.
  37. Yang SN, Liao CY, Chen SW, et al (2011). Clinical implications of the tumor volume reduction rate in head-and-neck cancer during definitive intensity-modulated radiotherapy for organ preservation. Int J Radiat Oncol Biol Phys, 79, 1096-103.

Cited by

  1. Adaptive radiotherapy for head and neck cancer vol.57, pp.10, 2018,
  2. Adaptive radiotherapy in head and neck cancer is required to avoid tumor underdose vol.57, pp.9, 2018,